FT Options’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

FT Options’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8,106	Closed	-$322K	–	440
2016 Q3	$322K	Buy	+8,106	New	+$90.4K	0.26%	78

FT Options's TBRA Position: Q4 2016 in Review

FT Options sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 8,106 shares — an estimated $322K sold.

FT Options first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $322K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

FT Options reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
FT Options sold 8,106 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $322K.
FT Options first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
FT Options's Tobira Therapeutics, Inc. Common Stock position peaked at $322K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on FT Options's 13F filing for Q4 2016, filed 10 Feb 2017.